Name (Synonyms) | Correlation | |
---|---|---|
drug951 | Flexitouch Plus with Cellular Connectivity (FT-CC) Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D000072656 | Breast Cancer Lymphedema NIH | 1.00 |
D008209 | Lymphedema NIH | 1.00 |
D001943 | Breast Neoplasms NIH | 0.50 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001004 | Lymphedema HPO | 1.00 |
HP:0003002 | Breast carcinoma HPO | 0.50 |
There is one clinical trial.
The aim of this possible study is to identify if SARS-CoV-2 can be found in the tear film and conjunctiva of a patient with COVID-19.
Description: The primary endpoint is the number of conjunctival swabs tested positive for SARS-CoV2.
Measure: SARS-CoV2 positive conjunctival swabs Time: 1 yearDescription: The secondary target is the difference between the conjunctival swab tested positive for SARS-CoV2 and the nasopharyngeal swab.
Measure: Conjunctival swab vs nasopharyngeal swab Time: 1 yearDescription: In the case of a SARS-COV 2 positive conjunctival swab a virus culture will be conducted to clarify, whether it is a viable virus or virus RNA fragments.
Measure: Viability of SARS-COV 2 Time: 1 year